These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17082246)

  • 1. Ligands to nucleic acid-specific toll-like receptors and the onset of lupus nephritis.
    Pawar RD; Patole PS; Ellwart A; Lech M; Segerer S; Schlondorff D; Anders HJ
    J Am Soc Nephrol; 2006 Dec; 17(12):3365-73. PubMed ID: 17082246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
    Patole PS; Gröne HJ; Segerer S; Ciubar R; Belemezova E; Henger A; Kretzler M; Schlöndorff D; Anders HJ
    J Am Soc Nephrol; 2005 May; 16(5):1326-38. PubMed ID: 15772251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
    Anders HJ; Vielhauer V; Eis V; Linde Y; Kretzler M; Perez de Lema G; Strutz F; Bauer S; Rutz M; Wagner H; Gröne HJ; Schlöndorff D
    FASEB J; 2004 Mar; 18(3):534-6. PubMed ID: 14734643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice.
    Sadanaga A; Nakashima H; Akahoshi M; Masutani K; Miyake K; Igawa T; Sugiyama N; Niiro H; Harada M
    Arthritis Rheum; 2007 May; 56(5):1618-28. PubMed ID: 17469144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral 5'-triphosphate RNA and non-CpG DNA aggravate autoimmunity and lupus nephritis via distinct TLR-independent immune responses.
    Allam R; Pawar RD; Kulkarni OP; Hornung V; Hartmann G; Segerer S; Akira S; Endres S; Anders HJ
    Eur J Immunol; 2008 Dec; 38(12):3487-98. PubMed ID: 19009528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus.
    Pawar RD; Ramanjaneyulu A; Kulkarni OP; Lech M; Segerer S; Anders HJ
    J Am Soc Nephrol; 2007 Jun; 18(6):1721-31. PubMed ID: 17460144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-rich DNA suppresses systemic lupus.
    Patole PS; Zecher D; Pawar RD; Gröne HJ; Schlöndorff D; Anders HJ
    J Am Soc Nephrol; 2005 Nov; 16(11):3273-80. PubMed ID: 16176997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor-7 modulates immune complex glomerulonephritis.
    Pawar RD; Patole PS; Zecher D; Segerer S; Kretzler M; Schlöndorff D; Anders HJ
    J Am Soc Nephrol; 2006 Jan; 17(1):141-9. PubMed ID: 16280469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of toll-like receptor-7 exacerbates lupus nephritis by modulating regulatory T cells.
    Gong L; Wang Y; Zhou L; Bai X; Wu S; Zhu F; Zhu YF
    Am J Nephrol; 2014; 40(4):325-44. PubMed ID: 25341693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
    Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
    Mannoor K; Matejuk A; Xu Y; Beardall M; Chen C
    J Immunol; 2012 Apr; 188(8):3628-38. PubMed ID: 22407922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
    J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
    Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K
    Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice.
    Elliott MK; Jarmi T; Ruiz P; Xu Y; Holers VM; Gilkeson GS
    Kidney Int; 2004 Jan; 65(1):129-38. PubMed ID: 14675043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice.
    Patole PS; Pawar RD; Lech M; Zecher D; Schmidt H; Segerer S; Ellwart A; Henger A; Kretzler M; Anders HJ
    Nephrol Dial Transplant; 2006 Nov; 21(11):3062-73. PubMed ID: 16954173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo.
    Lenert P; Yasuda K; Busconi L; Nelson P; Fleenor C; Ratnabalasuriar RS; Nagy PL; Ashman RF; Rifkin IR; Marshak-Rothstein A
    Arthritis Res Ther; 2009; 11(3):R79. PubMed ID: 19476613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon regulatory factor-1 gene deletion decreases glomerulonephritis in MRL/lpr mice.
    Reilly CM; Olgun S; Goodwin D; Gogal RM; Santo A; Romesburg JW; Ahmed SA; Gilkeson GS
    Eur J Immunol; 2006 May; 36(5):1296-308. PubMed ID: 16541466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice.
    Miyazaki T; Ono M; Qu WM; Zhang MC; Mori S; Nakatsuru S; Nakamura Y; Sawasaki T; Endo Y; Nose M
    Eur J Immunol; 2005 May; 35(5):1510-20. PubMed ID: 15832294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice.
    Hu L; Hu J; Chen L; Zhang Y; Wang Q; Yang X
    Front Immunol; 2021; 12():584414. PubMed ID: 33717066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.